Enzastaurin induces H2AX phosphorylation to regulate apoptosis via MAPK signalling in malignant glioma cells.

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Esther P Jane, Ian F Pollack

Abstract

Enzastaurin is an acyclic bisindolylmaleimide derived from staurosporine that acts as an ATP competitor, and interferes with the activity of protein kinase C (PKC) isoforms. Our previous studies have shown that clinically achievable concentrations of this agent induce apoptosis in many glioma cell lines. Our goal in this study was to expand on the previous results and to determine the signalling mechanisms responsible for enzastaurin-induced inhibition of cell growth and induction of apoptosis. To address these issues, cell cycle progression following enzastaurin treatment was analysed by fluorescence-activated cell sorting (FACS) in parallel with analyses of growth and apoptosis signalling pathways. Enzastaurin treatment activated H2AX and Chk2 phosphorylation, and enhanced phosphorylation of mitogen-activated protein kinase (MAPK) family kinases. Inhibition of MAP kinases by chemical inhibitors reduced H2AX and Chk2 phosphorylation and decreased apoptosis induced by enzastaurin. These data call attention to a novel signalling pathway (MAPK/H2AX) to regulate apoptosis in malignant glioma cells.

References

May 1, 1997·Current Opinion in Oncology·M NaganeW K Cavenee
Apr 16, 1998·The Journal of Biological Chemistry·E P RogakouW M Bonner
Sep 9, 1999·The Journal of Cell Biology·E P RogakouW M Bonner
Apr 13, 2001·Current Biology : CB·M Modesti, R Kanaar
Jun 8, 2001·Genes & Development·E A MaherR A DePinho
Mar 15, 2002·Current Opinion in Genetics & Development·Christophe RedonWilliam Bonner
Nov 7, 2002·Carcinogenesis·Simone BoldtWalter Kolch
Feb 26, 2003·Radiation Research·Paul DentRupert Schmidt-Ullrich
Aug 30, 2003·Oncogene·Paul DentSteven Grant
Nov 1, 2003·Cancer Chemotherapy and Pharmacology·Kristan A KeyesBeverly A Teicher
Sep 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael A CarducciRoy S Herbst
Sep 9, 2006·The Journal of Pharmacology and Experimental Therapeutics·Esther P JaneIan F Pollack
Jan 11, 2007·Annals of Neurology·Ghazaleh TabatabaiWolfgang Wick
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jeany M Rademaker-LakhaiEmile E Voest
Mar 4, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Yun OhGerold Bepler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.